Evidence map›Paper›PMID 33164487›Full record

ReviewChemical reviews2021

Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery.

Gina Porras, François Chassagne, James T Lyles, Lewis Marquez, Micah Dettweiler, Akram M Salam, Tharanga Samarakoon, Sarah Shabih, Darya Raschid Farrokhi, Cassandra L Quave

Abstract readReview
In one paragraph

Review in Chemical reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Molecules (Basel, Switzerland) · 2023
    Pooled it
  2. Article
  3. Article
  4. Callus Induction inPlants (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Integrated bioassays and metabolomics identifyFrontiers in microbiology · 2026
    Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gina PorrasCenter for the Study of Human Health, Emory University, 1557 Dickey Drive, Atlanta, Georgia 30322, United States.ORCID 0000-0002-2843-229X
François ChassagneCenter for the Study of Human Health, Emory University, 1557 Dickey Drive, Atlanta, Georgia 30322, United States.ORCID 0000-0003-4179-7995
James T LylesCenter for the Study of Human Health, Emory University, 1557 Dickey Drive, Atlanta, Georgia 30322, United States.ORCID 0000-0003-3111-6527
Lewis MarquezMolecular and Systems Pharmacology Program, Laney Graduate School, Emory University, 615 Michael Street, Whitehead 115, Atlanta, Georgia 30322, United States.ORCID 0000-0002-3782-5204
Micah DettweilerDepartment of Dermatology, Emory University, 615 Michael Street, Whitehead 105L, Atlanta, Georgia 30322, United States.
Akram M SalamMolecular and Systems Pharmacology Program, Laney Graduate School, Emory University, 615 Michael Street, Whitehead 115, Atlanta, Georgia 30322, United States.ORCID 0000-0002-0363-5795
Tharanga SamarakoonEmory University Herbarium, Emory University, 1462 Clifton Road NE, Room 102, Atlanta, Georgia 30322, United States.ORCID 0000-0003-3038-6170
Sarah ShabihCenter for the Study of Human Health, Emory University, 1557 Dickey Drive, Atlanta, Georgia 30322, United States.
Darya Raschid FarrokhiCenter for the Study of Human Health, Emory University, 1557 Dickey Drive, Atlanta, Georgia 30322, United States.
Cassandra L QuaveCenter for the Study of Human Health, Emory University, 1557 Dickey Drive, Atlanta, Georgia 30322, United States.ORCID 0000-0001-9615-7886

Funding

Novel compounds from botanical innovation yields Acinetobacter treatmentsR21AI136563 · NIAID · EMORY UNIVERSITY · PI QUAVE, CASSANDRA LEAH · 2018 to 2019
$443k
Preclinical evaluation of dietary botanical natural products for drug interactionsR21AT011105 · NCCIH · EMORY UNIVERSITY · PI QUAVE, CASSANDRA LEAH · 2020 to 2021
$429k
NCCIH NIH HHS R21 AT011105NIAID NIH HHS R21 AI136563
6 · The paper itself

Abstract

The crisis of antibiotic resistance necessitates creative and innovative approaches, from chemical identification and analysis to the assessment of bioactivity. Plant natural products (NPs) represent a promising source of antibacterial lead compounds that could help fill the drug discovery pipeline in response to the growing antibiotic resistance crisis. The major strength of plant NPs lies in their rich and unique chemodiversity, their worldwide distribution and ease of access, their various antibacterial modes of action, and the proven clinical effectiveness of plant extracts from which they are isolated. While many studies have tried to summarize NPs with antibacterial activities, a comprehensive review with rigorous selection criteria has never been performed. In this work, the literature from 2012 to 2019 was systematically reviewed to highlight plant-derived compounds with antibacterial activity by focusing on their growth inhibitory activity. A total of 459 compounds are included in this Review, of which 50.8% are phenolic derivatives, 26.6% are terpenoids, 5.7% are alkaloids, and 17% are classified as other metabolites. A selection of 183 compounds is further discussed regarding their antibacterial activity, biosynthesis, structure-activity relationship, mechanism of action, and potential as antibiotics. Emerging trends in the field of antibacterial drug discovery from plants are also discussed. This Review brings to the forefront key findings on the antibacterial potential of plant NPs for consideration in future antibiotic discovery and development efforts.

Indexed as

AlkaloidsAnimalsAnti-Bacterial AgentsAnti-Infective AgentsBiological ProductsDrug DiscoveryDrug Resistance, MicrobialHumansPhenolsPlant ExtractsPlantsStructure-Activity RelationshipTerpenesAlkaloidsAnti-Bacterial AgentsAnti-Infective AgentsBiological ProductsPhenolsPlant ExtractsTerpenes

Identifiers

PMID33164487
PMCPMC8183567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.